Tenenbaum A, Fisman EZ, Boyko V, Goldbourt U, Auerbach I, Shemesh J, Shotan A, Reicher-Reiss H, Behar S, Motro M: Prevalence and prognostic significance of unrecognized systemic hypertension in patients with diabetes mellitus and healed myocardial infarction and/or stable angina pectoris. Am J Cardiol. 1999, 84: 294-298. 10.1016/S0002-9149(99)00279-9.
Article
CAS
PubMed
Google Scholar
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined LV mass in the Framingham heart study. N Engl J Med. 1990, 322: 1561-1566.
Article
CAS
PubMed
Google Scholar
Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS: The Prognostic role of LVH in patients with or without coronary artery disease. Ann Intern Med. 1992, 117: 831-836.
Article
CAS
PubMed
Google Scholar
Liao Y, Cooper RS, McGee DL, Mensah GA, Ghali J: The relative effects of LVH, coronary artery disease and ventricular dysfunction on survival among black adults. JAMA. 1995, 273: 1592-1597. 10.1001/jama.273.20.1592.
Article
CAS
PubMed
Google Scholar
Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM: Losartan Intervention for Endpoint reduction in hypertension Study Investigations. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study. Circulation. 2003, 108: 684-690. 10.1161/01.CIR.0000083724.28630.C3.
Article
CAS
PubMed
Google Scholar
Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP: Echocardiographically detected LVH: prevalence and risk factors: the Framingham heart study. Ann Intern Med. 1988, 108: 7-13.
Article
CAS
PubMed
Google Scholar
Sasson Z, Rasooly Y, Bhesania T, Rasooly I: Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation. 1993, 88: 1431-1436.
Article
CAS
PubMed
Google Scholar
Watanabe K, Sekiya M, Tsuruoka T, Funada J, Kameoka H: Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension. J Hypertens. 1999, 17: 1153-1160. 10.1097/00004872-199917080-00015.
Article
CAS
PubMed
Google Scholar
Verdecchia P, Reboldi G, Schillaci G, Borgioni C, Ciucci A, Telera MP, Santeusanio F, Porcellati C, Brunetti P: Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation. 1999, 100: 1802-1807.
Article
CAS
PubMed
Google Scholar
Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY, Kitzman DW, Hopkins PN, Morgan D, Rao DC: Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation. 2001, 103: 102-107.
Article
CAS
PubMed
Google Scholar
Galvan AQ, Galetta F, Natali A, Muscelli E, Sironi AM, Cini G, Camastra S, Ferrannini E: Insulin resistance and hyperinsulinemia: No independent relation to left ventricular mass in humans. Circulation. 2000, 102: 2233-2238.
Article
CAS
PubMed
Google Scholar
Brown MJ, Castaigne A, Ruilope LM, Mancia G, Rosenthal T, de Leeuw PW, Ebner F: INSIGHT: International nifedipine GITS Study Intervention as a Goal in Hypertension Treatment. J Hum Hypertens. 1996, 10 (suppl 3): 157-160.
Google Scholar
Mancia G, Grassi G: The International Nifedipine GITS Study of Intervention as a Goal in Hypertension Treatment (INSIGHT) Trial. Am J Cardiol. 1998, 82: 23R-28R. 10.1016/S0002-9149(98)00753-X.
Article
CAS
PubMed
Google Scholar
Sahn DJ, DeMaria A, Kisslo J, Weyman A: Standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978, 58: 1072-1083.
Article
CAS
PubMed
Google Scholar
Devereux RB, Reicheck N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977, 55: 613-618.
Article
CAS
PubMed
Google Scholar
Savage DD, Garrison RY, Kannel WB, Levy D, Anderson SJ, Stokes J, Feinleib M, Castelli WP: The spectrum of left ventricular hypertrophy in a general population sample: the Framingham study. Circulation. 1987, 75 (Suppl I): 26-33.
Google Scholar
SAS Institute Inc: SAS/STAT User's Guide. Version 6, Cary, NC: SAS Institute Inc. 1989, 2: Fourth
Google Scholar
Tenenbaum A, Fisman EZ, Motro M: Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR). Cardiovasc Diabetol. 2003, 2: 4-10.1186/1475-2840-2-4.
Article
PubMed Central
PubMed
Google Scholar
Wilson PW, Grundy SM: The metabolic syndrome: practical guide to origins and treatment: Part I. Circulation. 2003, 108: 1422-1424. 10.1161/01.CIR.0000089505.34741.E5.
Article
PubMed
Google Scholar
Fisman EZ, Motro M, Tenenbaum A: Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof. Cardiovasc Diabetol. 2003, 2: 11-10.1186/1475-2840-2-11.
Article
PubMed Central
PubMed
Google Scholar
Rana BS, Band MM, Ogston S, Morris AD, Pringle SD, Struthers AD: Relation of QT dispersion to underlying cardiac abnormalities in diabetes mellitus. Am J Cardiol. 2002, 90: 483-487. 10.1016/S0002-9149(02)02518-3.
Article
PubMed
Google Scholar
Phillips RA, Krakoff LR, Dunaif A, Finegood DT, Gorlin R, Schimabukuro S: Relation among LV mass, insulin resistance and BP in non-obese subjects. J Clin Endocrinol Metab. 1998, 83: 4284-4288. 10.1210/jc.83.12.4284.
CAS
PubMed
Google Scholar
Galderisi M, Anderson KM, Wilson PW, Levy D: Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol. 1991, 68: 85-89.
Article
CAS
PubMed
Google Scholar
Galcera-Tomas J, Melgarejo-Moreno A, Garcia-Alberola A, Rodriguez-Garcia P, Lozano-Martinez J, Martinez-Hernandez J, Martinez-Fernandez S: Prognostic significance of diabetes in acute myocardial infarction. Are the differences linked to female gender?. Int J Cardiol. 1999, 69: 289-298. 10.1016/S0167-5273(99)00048-0.
Article
CAS
PubMed
Google Scholar
Marks JB, Raskin P: Cardiovascular risk in diabetes: a brief review. J Diabetes Complications. 2000, 14: 108-115. 10.1016/S1056-8727(00)00065-9.
Article
CAS
PubMed
Google Scholar
Hu G, DECODE Study Group: Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia. 2003, 46: 608-617.
CAS
PubMed
Google Scholar